Notice of Loan Conversion

Cambridge, UK - 24th May 2019

Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs, announces that it has received notice from Mr Alan Miller in accordance with the Convertible Loan Agreement dated 18 April 2017 (as amended) to convert the outstanding loan of £200,000 with accrued interest (“Loan”).

Download News

Back to all News